split-virion pandemic influenza vaccine (H5N1 strain NIBRG-14)
PRO-sPanFlu-2002
Phase 2 mab completed
Quick answer
split-virion pandemic influenza vaccine (H5N1 strain NIBRG-14) for Influenza is a Phase 2 program (mab) at China SXT Pharmaceuticals with 2 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Influenza
- Phase
- Phase 2
- Modality
- mab
- Status
- completed